News
Policy & Recommendations
EU Ministers of Health expressed their full support for the EU Global Health Strategy
The strategy, presented by the European Commission on 30 November 2022, puts global health forward as an essential pillar of EU external policy
|
ESWI Airborne: Meet the Members
Celebrating ESWI 30 years!
Who would have taken virus isolation for granted 30 years ago? How and why did ESWI transform from a pure virology-based network to one encompassing a public health perspective?
When to update COVID-19 vaccine composition
Vaccines against different SARS-CoV-2 variants have been approved, but continued surveillance is needed to determine when the antigen composition of vaccines should be updated, together with clinical studies to assess vaccine efficacy.
News
Reports
Policy & Recommendations
The European public health response to the COVID-19 pandemic: Lessons for future cross-border health threats
The early lessons from the pandemic underlined that challenges to health systems and economies, including supply chain problems and vaccine hesitancy, could no longer be overcome by European Union Member States acting alone.
European Parliament sets up new Public Health subcommittee
The subcommittee will deal with programmes and specific actions in the field of public health, pharmaceutical and cosmetic products, health aspects of bioterrorism, the European Medicines Agency, and the European Centre for Disease Prevention and Control.
COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022
COVID-19 vaccine effectiveness decreased with waning of vaccine-derived immunity and emerging Omicron sublineages.
Healthcare facilities should maintain and strengthen infection prevention and control measures during peaks of respiratory viruses transmission
ECDC recommends that healthcare facilities maintain and strengthen infection prevention and control measures, due to the high community transmission and co-circulation of respiratory viruses such as SARS-CoV-2, influenza, RSV and others.
EU-US conference on Long COVID
This online conference aimed to shed light on perspectives for addressing long COVID in the EU and the US. It brought together experts from medical, public health, health economics disciplines, patient organisations and policymakers.
WHO Webinar Series on Trust and Pandemic Preparedness: Trust and pandemics
The first webinar in the series reviews the lessons learned at the intersection of trust and different responses to health emergencies including HIV, Ebola and COVID-19.
Respiratory viruses and infection control
Health Europa spoke to Dr Albert Osterhaus about the burden of respiratory infections.
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
The global surge in the omicron (B.1.1.529) variant has resulted in many individuals with hybrid immunity (immunity developed through a combination of SARS-CoV-2 infection and vaccination).
Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19
SARS-CoV-2 infection is clinically heterogeneous, ranging from asymptomatic to deadly.
